Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group

Department Haematology, University Hospital Aarhus, Denmark
Department Radiotherapy and Oncology, Oulu University Hospital, Finland
Department Oncology, Norrlands University Hospital, Umeå, Sweden
Uppsala Academic Hospital, Sweden
Norwegian Department of Oncology, Radium Hospital, Oslo, Norway
Department of Oncology, Lund University Hospital, Sweden
Center of Haematology, Karolinska University Hospital, Solna, Sweden
Department of Oncology, Norwegian Radium Hospital, Oslo, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department Of Oncology, Helsinki University Hospital, Finland
Department of Diagnostic Imaging, MR Centre, Aarhus University Hospital, Denmark
Department of Oncology, University Hospital of Tromsø, Norway
Department of Oncology, St. Olav University Hospital, Trondheim, Norway;Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway
Vol. 100 No. 4 (2015): April, 2015